Glasgow

ECMC Glasgow

Glasgow ECMC aims to translate findings from laboratory programs and into clinical studies. In particular, the development of novel agents and using biological markers to optimise, target and individualise treatment. The Centre has an active early phase (phase I/II) clinical trial programme in both solid tumours and haematological malignancies.

Research Areas

Focus

Early drug development, telomerase therapeutics, drug and gene delivery, control of cellular senescence and apoptosis pathways, biomarker and pharmacodynamic endpoints.

Disease Area

Ovarian cancer, gastro-oesophageal cancer, colon cancer, carcinomas of unknown primary origin, refractory tumours (Phase I trials).

 

Goals

Goals

For further information on the goals and objectives of Glasgow ECMC go to:

More about Goals

 

Skills

Skills

Glasgow ECMC principal investigators and staff have a diverse range of skills and expertise.

More about Skills

 

Facilities

Facilities

Glasgow ECMC has access to a range of research facilities that are utilised in studies.

More about Facilities

 

Achievements

Achievements

To learn more about the scientific and operational achievements of Glasgow ECMC go to:

More Achievements

 

Centre Lead

Professor J Cassidy
Cancer Research UK Department of Medical Oncology
Cancer Research UK Experimental Therapeutics and Gene Medicine Group
Cancer Research UK Beatson Laboratories
Garscube Estate, Switchback Road, Bearsden
Glasgow
G61 1BD

 

General and Patient Enquiries

Professor Jim Cassidy
Tel: +44 (0) 141 330 4886 (office) or +44 (0) 141 330 4884 (Prof. Cassidy's PA)

You can also find out about trials recruiting in Glasgow on the CancerHelp UK clinical trials database.